AOC grills pharma exec about why the HIV-prevention drug Prep costs $8 in Australia costs $1,780 in the USA

Gilead makes a drug called Truvada -- AKA Prep -- that was developed at US taxpayer expense, whose patents are held by the US government; Truvada is on track to eliminating the spread of HIV forever (people who are HIV positive but take Truvada are seemingly not infectious), but taking Truvada in the USA (where the patents haven't expired) is incredibly expensive, running $1,780/month, whereas in Australia, it's available as a generic for $8/month. Read the rest

One year 40% HIV infection dropoff in London attributed to grey-market generic pre-exposure prophylaxis drugs

Taking pre-exposure prophylaxis drugs like Truvada before having unprotected sex with HIV+ people can significantly reduce the risk of infection (the drugs can also be taken after potential exposure); though this use is approved in England, the NHS does not yet cover Truveda prescriptions, so people who wish to take the drug are expected to pay £400/month. Read the rest